Acute quadriplegic myopathy with myosin-deficient muscle fibres after liver transplantation: Defining the clinical picture and delimiting the risk factors

Transplantation

Volumn 67, Issue 8, 1999, Pages 1144-1151

  Miró, Òscar ^a   Salmerón, Joan M ^a   Masanés, Ferran ^a   Alonso, Josep R ^a   Graus, Francesc ^a   Mas, Antoni ^a   Grau, Josep M ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; MIDAZOLAM; MORPHINE SULFATE; MYOSIN; PROPOFOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MUSCLE CELL; MYOPATHY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; QUADRIPLEGIA; RISK FACTOR; ULTRASTRUCTURE;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MUSCLE FIBERS; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSINS; POSTOPERATIVE COMPLICATIONS; QUADRIPLEGIA; REFLEX, ABNORMAL; RISK FACTORS;

EID: 0033609023     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904270-00010     Document Type: Article

References (46)

1. McFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977; 11: 615.
2. Hirano M, Ott Br, Raps EC, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992; 42: 2082.
3. Miró O, Grau JM, Nadal P, Picado C, Plaza V, Urbano-Márquez A. Miopatía aguda en relación con la administratión de glucocorticoides y bloqueadores neuromusculares. Med Clin (Bare) 1994; 103: 458.
4. Hanson P, Dive A, Brucher JM, Bisteau M, Daugoise M, Deltombe T. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997; 20: 1371.
5. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996; 40: 645.
6. Al-Lozi MT, Pestronk A, Yee WC, Flaris N, Cooper J. Rapidly evolving myopathy with myosin-deficient muscle fibres. Ann Neurol 1994; 35: 273.
7. Wijdicks EFM, Litchy WJ, Wiesner RH, Krom RAF. Neuromuscular complications associated with liver transplantation. Muscle Nerve 1996; 19: 696.
8. Faragher MW, Day BJ, Dennett X. Critical care myopathy: an electrophysiological and histological study. Muscle Nerve 1996; 19: 516.
9. Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani MJ. Acute myopathy after liver transplantation. Neurology 1998; 50: 46.
10. Subramony SH, Carpenter DE, Raju S, Pride M, Evans OB. Myopathy and prolonged neuromuscular blockade after lung transplant. Crit Care Med 1991; 19: 1580.
11. Rull R, García-Valdecasas JC, Grande L, et al. Outcome after liver transplantation. Differences between two time periods: 1988-1991 and 1992-1995. Transplant Proc 1997; 29: 471.
12. Grande L, Rimola A, Cugat E, et al. Effect of venovenous bypass on perioperative renal function in liver transplantation: results of a randomized controlled trial. Hepatology 1996; 23: 1418.
13. Gilabert R, Bargalló X, Forns X, et al. Value of dupplex-doppler ultrasound findings in liver transplant recipients with initial poor graft function. Transplantation 1996; 61: 832.
14. Beltran J, Taura P, García-Valdecasas JC, et al. Neurological disorders and intraoperative factors in liver transplantation. Transplant Proc 1993; 25: 1749.
15. Castells A, Salmerón JM, Navasa M, et al. Liver transplantation for acute liver failure: Analysis of applicability. Gastroenterology 1993; 105: 532
16. Llach J, Rimola A, Arroyo V, et al. Trasplante hepático: selección de caiididatos y resultados obtenidos en un programa para pacientes adultos. Med Clin (Barc) 1991; 96: 41.
17. Saló J, Mas A, Navasa M, et al. Complicaciones del trasplante hepático durante el control postoperatorio en cuidados intensives. Análisis de 100 casos. Gastroenterol Hepatol 1991; 14: 429.
18. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus in bleeding oesophageal varices. Br J Surg 1973; 60: 648.
19. Knaus M, Draper EA, Wagner DP, Zimmerman JE. Apache II: a severity of disease classification system. Crit Care Med 1985; 13: 818.
20. Seneff M, Knaus WA. Predicting patient outcome from intensive care: a guide to APACHE, MPM, SAPS, PRISM, and other prognostic scoring systems. J Intensive Care Med 1990; 5: 33.
21. Grande L, Rimola A, García-Valdecasas JC, et al. Recovery of liver graft after initial poor function. Transplantation 1992; 53: 228.
22. González FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20: 565.
23. Miró O, Pedrol E, Casademont J, et al. Muscle involvement in rheumatoid arthritis: clinicopathological study of 21 symptomatic cases. Semin Arthritis Rheum 1996; 25: 421.
24. Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A. Human immunodeficiency virus type I infection and myopathy: clinical relevance of zidovudine therapy. Ann Neurol 1993; 34: 206.
25. Adams DH, Gunson B, Honigsberger L, et al. Neurologic complications following liver transplantation. Lancet 1987; 1: 949.
26. Vogt DP, Lederman RJ, Carey WD, Broughan TA. Neurologic complications of liver transplantation. Transplantation 1988; 45: 1057.
27. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA. Neurologic complications following liver transplantation. Ann Neurol 1992; 31: 644.
28. Pujol A, Graus F, Rimola A, et al. Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994; 44: 1226.
29. Rich MM, Pinter MJ, Kraner SD, Barchi SL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998; 43: 171.
30. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller MD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327: 524.
31. Danon MJ, Carpenter S. Myopathy with thick filaments (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991; 14: 1131.
32. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid treated rat solei after denervation and reinnervation. Muscle Nerve 1992; 15: 1290.
33. Bronster DJ, Yonover P, Stein J, Scelsa SN, Miller CM, Sheiner PA. Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation 1995; 59: 1066.
34. Fernández-Solá J, Campistol JM, Casademont J, Grau JM. Reversible cyclosporine myopathy. Lancet 1990; 335: 362.
35. Anderson CF, Loosbrock LM, Moxness KE. Nutrient intake in critically ill patients: too many or too few calories? Mayo Clin Proc 1986; 61(11): 853.
36. Shizgal HM, Martin MF. Caloric requirement of the critically ill septic patient. Crit Care Med 1988; 16: 312.
37. Iapichino G, Radrizzani D, Solca M, et al. The main determinants of nitrogen balance during total parenteral nutrition in critically ill injured patients. Intensive Care Med 1984; 10: 251.
38. Jeevanandam M, Young DH, Schiller WR. Influence of parenteral nutrition on rates of net substrate oxidation in severe trauma patients. Crit Care Med 1990; 18: 467.
39. Frankenfield DC, Smith JS, Cooney RN. Accelerated nitrogen loss after traumatic injury is not attenuated by achievement of energy balance. J Parenter Enteral Nutr 1997; 21: 324.
40. Radrizzani D, Iapichino G, Scherini A, et al. Main nitrogen balance determinants in malnourished patients. Intensive Care Med 1986; 12: 308.
41. Hunter DC, Jaksic T, Lewis D, Benotti PN, Blackburn GL, Bistrian BR. Resting energy expenditure in the critically ill: estimations versus measurement. Br J Surg 1988; 75: 875.
42. Minetti C, Hirano M, Morreale G, et al. Ubiquitin expression in acute steroid myopathy with loss of thick filaments. Muscle Nerve 1996; 19: 94.
43. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997; 20: 316.
44. Chad DA, Lacomis D. Critically ill patients with newly acquired weakness: the clinicopathological spectrum. Ann Neurol 1994; 35: 257.
45. Rich MM, Raps EC, Bird SJ. Distinction between acute myopathy syndrome and critical illness polyneuropathy. Mayo Clin Proc 1995; 70: 198.
46. Grau JM, Miro O. Polineuropatía del enfermo crítico. Neurología 1996; 11: 287.